1st August 2008:

Aurora BioScience announces exclusive distribution agreement with Fenwal Inc.

Aurora BioScience Pty. Ltd. today announced that it has reach agreement to become the exclusive distributor for US based blood technology company Fenwal Inc.. Under the agreement Aurora Bioscience will be exclusively responsible for the sales, marketing and distribution in both the Australian and New Zealand markets.

For over 50 years, Fenwal has pioneered the science of blood technologies; introducing breakthroughs that have helped make blood collection and therapy a reality. Today, Fenwal continues to be a world leader in the development of innovations that change the practice of blood transfusion and help to ensure a safe and available global blood supply.

“After an extensive evaluation of the potential options to best serve the local healthcare market, Fenwal Inc. have renewed an old partnership and signed a new distribution agreement with Aurora BioScience Pty Ltd. The principals of Aurora BioScience have a combined 40 years of experience of working in the transfusion business and also with the ARCBS during their time with Baxter Healthcare both in Australia and overseas.  It was their extremely detailed knowledge of the Fenwal products, their dedication to exceeding customer expectations and their past understanding of ARCBS requirements that has lead Fenwal Inc. to contract Aurora BioScience as our new Australian Distributors” said Mr Dean Gregory, Senior Vice President Global Sales & Commercial Operations - Fenwal Inc..                        

From the first flexible, disposable Blood-Pack® unit to advanced apheresis technology, Fenwal has a history of developing innovative products to support the needs of blood and plasma centres. Fenwal’s comprehensive portfolio of automated collection systems provides high-quality, flexible component collection and processing for fixed and mobile blood collection environments whilst offering a full range of whole-blood products and services that are adaptable to all blood collection needs.

"We are extremely excited to be again associated with this innovative company and their blood collection and processing technologies. We strongly believe that the Fenwal automated range of products offer a truly distinct and innovative alternative for the transfusion medicine community " said Darren Banks, Managing Director of Aurora BioScience.

“We at Fenwal were extremely pleased to be able to have Aurora BioScience once again working on the company’s product portfolio and we hope that the transfusion community will be as equally pleased to have such a knowledgeable team supporting you with any needs related to the Fenwal products” stated Mr Gregory.

Aurora BioScience can be contacted on 1300 309 994 or by fax on 02 9838 7621 for information or support with the range of Fenwal products.

 

 

About Fenwal

Fenwal is a leading, global healthcare company focused on the development, manufacture and marketing of products and services for the transfusion medicine industry. The company provides a comprehensive portfolio of products and services for manual and automated blood collection, processing and storage. For more information, please visit www.fenwalinc.com.

 

Click here to return to Main News Page.